or Try an Advanced Search...

    Technical Analysis for HRMY - Harmony Biosciences Holdings, Inc.

    Grade Last Price % Change Price Change
    D 31.00 -0.16% -0.05
    HRMY closed down 0.16 percent on Friday, December 8, 2023, on 61 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions.
    7 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Strong Down Up Up
    Historical HRMY trend table...
    Date Alert Name Type % Chg
    NR7 Range Contraction 0.00%
    Inside Day Range Contraction 0.00%
    Wide Bands Range Expansion 0.00%
    Overbought Stochastic Strength 0.00%
    Down 3 Days in a Row Weakness 0.00%
    Slingshot Bullish Bullish Swing Setup -0.16%
    Wide Bands Range Expansion -0.16%
    Overbought Stochastic Strength -0.16%
    Wide Bands Range Expansion -3.31%
    Gapped Up Strength -3.31%
    Older End-of-Day Signals for HRMY ...

       Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

    Alert Time
    Possible NR7 2 days ago
    Possible Inside Day 2 days ago
    60 Minute Opening Range Breakdown 2 days ago
    Up 2% 2 days ago
    Up 1% 2 days ago
    View Earlier Intraday Alerts

    Get this analysis on your stocks daily!

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Get Started for Free!
    Configure default chart indicators
    HRMY Chart by TradingView
    Basic chart:

    Profile

    Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, focuses on developing and commercializing therapies for patients living with rare neurological disorders. Its lead product includes WAKIX (pitolisant) for the treatment of pediatric patients suffering from narcolepsy. Harmony Biosciences Holdings, Inc. was formerly known as Harmony Biosciences II, Inc. and changed its name to Harmony Biosciences Holdings, Inc. in February 2020. The company was founded in 2017 and is based in Plymouth Meeting, Pennsylvania.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Pharmaceutical Neurological Disorders Stage Pharmaceutical Ethers Urological Disorders Chloroarenes Narcolepsy Piperidines Rare Neurological Disorders Stimulants

    Is HRMY a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 2 bullish, 2 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Dec 7 HRMY or GMAB: Which Is the Better Value Stock Right Now?
    Dec 7 HARMONY BIOSCIENCES ANNOUNCES POSITIVE TOPLINE DATA FROM PHASE 2 SIGNAL DETECTION STUDY EVALUATING PITOLISANT IN ADULT PATIENTS WITH MYOTONIC DYSTROPHY TYPE 1
    Dec 5 16 Most Undervalued Small-Cap Stocks To Buy According To Hedge Funds
    Dec 5 HARMONY BIOSCIENCES TO PRESENT RESULTS FROM BEHAVIORAL STUDY IN 22Q11.2 DELETION SYNDROME AT AMERICAN COLLEGE OF NEUROPSYCHOPHARMACOLOGY ANNUAL MEETING
    Nov 29 Wall Street Analysts Predict a 44.38% Upside in Harmony Biosciences Holdings, Inc. (HRMY): Here's What You Should Know
    Nov 21 HRMY vs. REGN: Which Stock Is the Better Value Option?
    Nov 19 Is Harmony Biosciences Holdings, Inc.'s (NASDAQ:HRMY) Stock's Recent Performance Being Led By Its Attractive Financial Prospects?
    Nov 16 HARMONY BIOSCIENCES TO PARTICIPATE IN PIPER SANDLER 35th ANNUAL HEALTHCARE CONFERENCE
    Nov 15 HARMONY BIOSCIENCES RANKED AMONG TOP 25 FASTEST-GROWING COMPANIES IN NORTH AMERICA ON THE 2023 DELOITTE TECHNOLOGY FAST 500™
    Nov 13 How Much Upside is Left in Harmony Biosciences Holdings, Inc. (HRMY)? Wall Street Analysts Think 76.62%
    See more HRMY news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 61.4
    52 Week Low 18.6112
    Average Volume 789,252
    200-Day Moving Average 33.48
    50-Day Moving Average 26.67
    20-Day Moving Average 28.42
    10-Day Moving Average 30.46
    Average True Range 1.33
    RSI (14) 64.16
    ADX 30.91
    +DI 33.84
    -DI 17.30
    Chandelier Exit (Long, 3 ATRs) 29.04
    Chandelier Exit (Short, 3 ATRs) 26.88
    Upper Bollinger Bands 33.48
    Lower Bollinger Band 23.37
    Percent B (%b) 0.76
    BandWidth 35.56
    MACD Line 1.56
    MACD Signal Line 1.20
    MACD Histogram 0.358
    Fundamentals Value
    Market Cap 1.76 Billion
    Num Shares 56.9 Million
    EPS
    Price-to-Sales 22.86
    Price-to-Book 26.47
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 32.34
    Resistance 3 (R3) 32.48 32.17 32.12
    Resistance 2 (R2) 32.17 31.83 32.10 32.04
    Resistance 1 (R1) 31.59 31.62 31.43 31.45 31.97
    Pivot Point 31.28 31.28 31.20 31.21 31.28
    Support 1 (S1) 30.69 30.93 30.54 30.55 30.03
    Support 2 (S2) 30.38 30.72 30.31 29.96
    Support 3 (S3) 29.80 30.38 29.88
    Support 4 (S4) 29.66